Corrigendum to "A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients" [Radiother Oncol 156 (2021) 127-135]
Radiother Oncol. 2021 Oct:163:244.
doi: 10.1016/j.radonc.2021.03.037.
Epub 2021 Jun 10.
1 Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: [email protected].
2 Department of Bioinformatics, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
3 Department of Statistics, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
4 Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
5 Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
6 Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
7 Department of Radiation Oncology, Institute Curie, Paris, France.
8 Department of Radiation Oncology, Iridium Netwerk, Wilrijk Antwerp, Belgium; University of Antwerp, Edegem Antwerp, Belgium.
9 Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, the Netherlands.
10 Department of Pathology, Amsterdam UMC, Amsterdam, the Netherlands.